Cite
HARVARD Citation
Alexeeva, E. et al. (n.d.). THU0506 LONG-TERM EFFECTIVENESS AND SAFETY OF CANAKINUMAB AS A SECOND BIOLOGIC AFTER TOCILIZUMAB IN CHILDREN WITH EARLY AND LATE JIA WITH ACTIVE SYSTEMIC FEATURES. Annals of the rheumatic diseases. pp. 491-492. [Online].